JSF Financial’s Gilead Sciences GILD Stock Holding History

JSF Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.35M	Sell	9,651 -513	-5%	-$71.8K	0.26%	49
2025 Q4	$1.25M	Buy	+10,164	New	+$1.24M	0.26%	52

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JSF Financial's GILD Position: Q1 2026 in Review

JSF Financial reduced its Gilead Sciences (GILD) stake by 5% in Q1 2026, selling an estimated $71.8K and leaving 9,651 shares worth $1.35M. The position accounts for 0.26% of the portfolio, ranked #49.

JSF Financial first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

JSF Financial held 9,651 shares of Gilead Sciences worth $1.35M as of Q1 2026.
JSF Financial sold 513 Gilead Sciences shares in Q1 2026, an estimated $71.8K.
Gilead Sciences made up 0.26% of JSF Financial's portfolio in Q1 2026, its #49 holding.
JSF Financial first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on JSF Financial's 13F filing for Q1 2026, filed 7 May 2026.